Dalrada (DFCO) Removes Shell Company Status.

LIVE QUOTE SAN DIEGO, Nov. 6, 2020 SAN DIEGO , Nov. 6,...
Dalrada, Biotech Stock Review

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared...
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...
Issam Radd

Citius Pharma (CTXR) Shareholder Letter | Year Ahead Roadmap.

2021 and 2020 Milestones In Plain Sight. Locked and Loaded for most of 2020 - many major milestone...
Hepion, Biotech Stock Review

Hepion Pharma (HEPA): News Archive

UPDATED CONTINUOUSLY.. 12/31/2020: News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10. 12/23/2020: Remember...
CB Scientific, Biotech Stock Review

Adding Telehealth Play CB Scientific (CBSC) $1.10 to CoronaVirus Watch List.

MyCardia's My-Cam Offers At-Home Heart Rate Monitoring. LIVE QUOTE

Shark Tanks’ Kevin Harrington Gets Into Sanitizer Business.

Aphex BioCleanse Systems Welcomes Original Shark Tank Investor Kevin Harrington and World-Renowned Entrepreneur Mark Timm as Advisors
Dalrada

Adding Dalrada (DFCO) $0.09 to CoronaVirus Stock Watch List.

LIVE QUOTE Adding Dalrada (DFCO), a technology Incubator with interests in telehealth and...

Citius Pharma (CTXR) Video Presentation.

Chairman Leonard Mazur Discusses: Mino-Lok Treatment for Infected Catheters. Novellus Stem Cell Treatment...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...